A novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors. (March 2018) - Medina, J.; Hinterberger, M.; Testori, M.; Geiger, M.; Giessel, R.; Bathke, B.; Kassub, R.; Graebnitz, F.; Fiore, G.; Chaplin, P.; Hochrein, H.; Lauterbach, H.